Recent

% | $
Quotes you view appear here for quick access.

US Airways Group, Inc. Message Board

joesolomon333 372 posts  |  Last Activity: Jun 29, 2015 2:31 PM Member since: Oct 23, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Looks like Sandoz launched generic today

    by zeusman8 Apr 24, 2015 6:36 PM
    joesolomon333 joesolomon333 Apr 26, 2015 8:05 AM Flag

    Looks like you are in denial.
    It is clear that you have sold your soul to the Devil Hedgie Shorts. Hope you feel good about who you are and what you do.

  • Reply to

    Federal Circuit Update

    by joesolomon333 Apr 27, 2015 1:24 PM
    joesolomon333 joesolomon333 Apr 27, 2015 2:30 PM Flag

    I did not say any of that. Most importantly, Judge Navarro is a "she" not a "he". I rest my case.

  • Reply to

    Federal Circuit Update

    by joesolomon333 Apr 27, 2015 1:24 PM
    joesolomon333 joesolomon333 Apr 27, 2015 2:04 PM Flag

    Also, keep your eyes on Claims 5 - 9. Judge Navarro in Nevada ruled that these patent claims were invalid as a matter of law and SPPI did not even get to argue the factual validity. That ruling alone could cause the entire decision to be overturned.

  • Reply to

    went long again

    by stocks.toshort Apr 28, 2015 10:53 AM
    joesolomon333 joesolomon333 Apr 28, 2015 2:31 PM Flag

    Maybe you should just stick with index funds. All said, perhaps that is the best route for you.

  • joesolomon333 by joesolomon333 Apr 29, 2015 5:36 PM Flag

    You guys are seriously making me start to worry about the future of the world. eom

  • Reply to

    yekafena, goofy and short babbling

    by joesolomon333 Apr 29, 2015 5:36 PM
    joesolomon333 joesolomon333 Apr 29, 2015 7:01 PM Flag

    Goofy,
    Yekafena, short babbling and you should each please go double check the solvency of the hedge funds who are paying you. They have to be in the final stages of serious budget cuts as evidenced by your posts on this message board.
    Really, you should check right away because they will toss you to the curb in a heartbeat when their investors pull their funds. Things are not right and the budget is being shredded to the breaking point.

  • Reply to

    My Dream

    by alfankosh22 May 3, 2015 2:48 PM
    joesolomon333 joesolomon333 May 3, 2015 3:38 PM Flag

    Three important follow-up questions:
    1. Did you see Raj at all in your dream and, most importantly, was he there when you woke up?
    2. Did you also happen to see Venice at all in the dream?
    3. Could you tell what year it was?

    We will see if we can "figure this out" a little more. TIA

  • Reply to

    SPECTRUM PHARMACEUTICALS, INC. v. BURWELL et al

    by iome70 Apr 30, 2015 3:53 AM
    joesolomon333 joesolomon333 May 3, 2015 6:51 PM Flag

    iome, iome, iome,
    really? You do not have a clue.

    First, it is "injunction" not "injection" in the United States.

    Second, do you have any idea as to what SPPI's burden of proof is in the Motion for a Permanent Injunction in order to have any chance of being successful? Please do some research and then you will have a better understanding. TIA

  • Reply to

    Note to the toadies (shorts)....

    by markbuti May 7, 2015 8:03 PM
    joesolomon333 joesolomon333 May 7, 2015 9:34 PM Flag

    There are other game changing events as well:
    1. Sandoz loses the May 18th Orphan Drug case and can't sell 175 or 250 mg vials for colorectal cancer.
    2. Sandoz loses the Federal Circuit case and the patent is upheld.
    3. CE Meph sales are meaningful.
    4. Apaz receives Panel Review and a recommendation of approval.
    5. SPI-2012 preliminary Phase III data reconfirms Phase II bioequivalent or better.
    6. Poziotinib is still a little to far away but good Phase II will increase any future buyout price dramatically.

    Problem is, the Sandoz cases and CE Melph are the only 3 opportunities this year.

  • Reply to

    Any thoughts?

    by joesolomon333 May 15, 2015 7:53 PM
    joesolomon333 joesolomon333 May 15, 2015 10:35 PM Flag

    Good article Zeus. Written by Martin Lipton, a serious NY M&A attorney. I think the heat will be turned up a lot and it will get real interesting if:

    1. Another hedge or Tute publicly supports Armistice and also files a 13F; or
    2. Armistice notices a Special Shareholders' Meeting; or
    3. A hostile buyout offer is announced.

    Any of those and show is on. The best thing SPPI can do is get those Apaz and SPI-2012 trials going, forget that Comp plan and hope CE Melph is approved early.

  • joesolomon333 by joesolomon333 May 15, 2015 7:53 PM Flag

    On Armistice's next move. You don't start something like this if you are a "one trick" pony. What do you think the next moves are?

  • joesolomon333 by joesolomon333 May 29, 2015 1:04 PM Flag

    Imho, ville, iome, sts, biosht, db,

    You guys have a serious case of p []enis envy. If you really want to see it, please come to the shareholders’ meeting and I will show you how big it is. Trust me, it is bigger than yours. Have a great weekend, Joe

  • Reply to

    tartiaboy, antihama, others - re Apaziquone

    by ville_9 Jun 11, 2015 6:15 AM
    joesolomon333 joesolomon333 Jun 11, 2015 8:02 AM Flag

    Now, you are starting to think ville. The answer could be the very worst nightmare for you and the shorts.

    Thusm I will ask you a question: Why does SPPI's Corporate May Presentation not mention any Phase III for Apaziquone and only an NDA filing unlike the repeated references and milestone mentions of Phase III and II study commencements for SPI-2012 and Poziotinib. No mention at all of any Apaz study. Simply an NDA filing.

    You don't think the FDA is letting SPPI merely combine its prior Phase III data from the prior years and show the effect without blood in the bladder do you? Hence, re-submit data and re-file.

  • Reply to

    sherryjoemarkbuti

    by stocks.toshort Jun 29, 2015 1:46 PM
    joesolomon333 joesolomon333 Jun 29, 2015 2:31 PM Flag

    Incorrect once again.

    Also, when the market drops 30%, your UPRO will go to Zero and your account will be closed. That is what Triple Margin does. just sayin

  • Reply to

    This is WHY Iome is a short.....

    by sherrysgone Apr 2, 2015 7:21 AM
    joesolomon333 joesolomon333 Apr 2, 2015 7:33 AM Flag

    Iome. Sell your shares and move on. You have lost sight of reality altogether and do not have the fortitude to see SPPI's future nor do you deserve to share in it.

  • Reply to

    goofy is bipolar

    by joesolomon333 Apr 3, 2015 9:23 PM
    joesolomon333 joesolomon333 Apr 3, 2015 11:19 PM Flag

    Problem is....they are the JV team. Also, they have Alzheimer's as they cannot even remember what they say day to day much less several days ago.

    As a result, there is no consistency or substance to their game plan. Even cigan could help teach them a little which is a "big" statement. These must be the small Hedgie's JV team. embarrassing.

  • Reply to

    goofy is bipolar

    by joesolomon333 Apr 3, 2015 9:23 PM
    joesolomon333 joesolomon333 Apr 3, 2015 10:14 PM Flag

    Two Blockbuster Biotech! Exciting times joevictory!

  • Reply to

    Saturday SPPI 4 April, 2015

    by reppeptgs Apr 4, 2015 9:31 AM
    joesolomon333 joesolomon333 Apr 4, 2015 2:27 PM Flag

    Mark,
    1. The Noteholders can convert early but SPPI generally has NO right to redeem or prepay the Notes prior to the December 15, 2018 Maturity Date. Exhibit 4.1, Article 4.
    2. SPPI also entered into a warrant hedge agreement with RBC so there would be Zero Dilution below $14.03 PPS which was 70% above the PPS at closing. Thus, the conversion is at $10.53 but if the PPS is higher, then the dilution only hurts to the extent the PPS is above $14.03. Form 8-K, Page 3, paragraph 5.

    Please confirm, but it would seem:

    1. Pull the rug out from under the Noteholders so there is no possibility that they will receive shares if the PPS is above the $10.53 agreed conversion price. Thus, their upside hedge on their short position is effectively gone. Plus, they no longer have any assurance they will receive anything other than a repayment of their loan in Cash only.
    2. Continue to drive Revenues and Earnings Growth with CE MELPH, APAZ, SPI-2012 and P results and/or NDA approvals.
    3. If PPS, is $30, $40, $80 by December 2018, (i) enter into a Line of Credit and pay them in cash or (ii) do a small secondary at $80 for 1.5 million shares and pay them off.

  • Reply to

    Saturday SPPI 4 April, 2015

    by reppeptgs Apr 4, 2015 9:31 AM
    joesolomon333 joesolomon333 Apr 4, 2015 3:27 PM Flag

    Take a look at page 57 of Exhibit 4.1. Complicated, but there is an adjustment from the $10.53 PPS Conversion Rate price per share under 11.03(b)(v)(B) for all cash settlements or combination settlements under subsection (C).

  • Reply to

    What's Really Going On with Spectrum

    by joesolomon333 Mar 29, 2015 4:09 PM
    joesolomon333 joesolomon333 Apr 4, 2015 11:11 PM Flag

    16. Short interest over 19.5 million with only 65.5 million shares outstanding.